These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37700827)

  • 1. Establishment of a primary renal lymphoma model and its clinical relevance.
    Li X; Deng M; Zhang C; Luo L; Qian H
    Front Oncol; 2023; 13():1089187. PubMed ID: 37700827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1.
    Delage L; Lambert M; Bardel É; Kundlacz C; Chartoire D; Conchon A; Peugnet AL; Gorka L; Auberger P; Jacquel A; Soussain C; Destaing O; Delecluse HJ; Delecluse S; Merabet S; Traverse-Glehen A; Salles G; Bachy E; Billaud M; Ghesquières H; Genestier L; Rouault JP; Sujobert P
    Blood; 2023 Mar; 141(10):1209-1220. PubMed ID: 36375119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of USP18 reduces tumor-infiltrating activated dendritic cells in extranodal diffuse large B cell lymphoma patients.
    Zhao C; Huang R; Zeng Z; Yang S; Lu W; Liu J; Wei Y; Guo H; Zhang Y; Yan P; Huang Z; Shi J
    Aging (Albany NY); 2021 May; 13(10):14131-14158. PubMed ID: 34001679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No difference in treatment outcome between patients with nodal versus extranodal diffuse large B-cell lymphoma.
    Khan SR; Muhammad A; Soomar SM; Shoaib D; Arshad Ali A; Muhammad T; Zahir MN; Abdul Jabbar A; Abdul Rashid Y; Heger M; Moosajee MS
    J Clin Transl Res; 2023 Feb; 9(1):37-49. PubMed ID: 36687299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma.
    Shen R; Xu PP; Wang N; Yi HM; Dong L; Fu D; Huang JY; Huang HY; Janin A; Cheng S; Wang L; Zhao WL
    Clin Transl Med; 2020 Nov; 10(7):e221. PubMed ID: 33252851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A strong host response and lack of MYC expression are characteristic for diffuse large B cell lymphoma transformed from nodular lymphocyte predominant Hodgkin lymphoma.
    Schuhmacher B; Rengstl B; Döring C; Bein J; Newrzela S; Brunnberg U; Kvasnicka HM; Vornanen M; Küppers R; Hansmann ML; Hartmann S
    Oncotarget; 2016 Nov; 7(44):72197-72210. PubMed ID: 27708232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Type3 (Non-ABC, Non-GCB) Subtype of Extranodal Diffuse Large B-Cell Lymphoma of the Thyroid Bearing No
    Nishi Y; Kitazawa R; Haraguchi R; Ouchi A; Ueda Y; Kamaoka Y; Yamamoto K; Todo Y; Miyaoka H; Kitazawa S
    Case Rep Oncol; 2017; 10(2):508-514. PubMed ID: 28690525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
    Shen R; Fu D; Dong L; Zhang MC; Shi Q; Shi ZY; Cheng S; Wang L; Xu PP; Zhao WL
    Signal Transduct Target Ther; 2023 Apr; 8(1):145. PubMed ID: 37032379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.
    Ollila TA; Olszewski AJ
    Curr Treat Options Oncol; 2018 Jun; 19(8):38. PubMed ID: 29931605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CLINICAL CHARACTERISTICS OF PRIMARY EXTRANODAL VERSUS NODAL DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE COHORT STUDY IN A CANCER CENTER.
    Candelaria M; Oñate-Ocaña LF; Corona-Herrera J; Barrera-Carmona C; Ponce-Martínez M; Gutiérrez-Hernández O; Avilés-Salas A; Cacho-Díaz B
    Rev Invest Clin; 2019; 71(5):349-358. PubMed ID: 31599881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in mice.
    Nemajerova A; Petrenko O; Trümper L; Palacios G; Moll UM
    J Clin Invest; 2010 Jun; 120(6):2070-80. PubMed ID: 20484818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.
    Pillai RK; Sathanoori M; Van Oss SB; Swerdlow SH
    Am J Surg Pathol; 2013 Mar; 37(3):323-32. PubMed ID: 23348205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma.
    Kleo K; Dimitrova L; Oker E; Tomaszewski N; Berg E; Taruttis F; Engelmann JC; Schwarzfischer P; Reinders J; Spang R; Gronwald W; Oefner PJ; Hummel M
    BMC Cancer; 2019 Apr; 19(1):322. PubMed ID: 30953469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct gene expression profiles: nodal versus extranodal diffuse large B-cell lymphoma.
    Jehan Z; Siraj AK; Abubaker J; Ruiz C; Simon R; Sultana M; Uddin S; Bavi P; Hussain A; Razack S; Ezzat A; Al-Dayel F; Sauter G; Al-Kuraya KS
    Oncology; 2008; 75(1-2):71-80. PubMed ID: 18784434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of B-cell translocation gene 1-controlled gene networks in diffuse large B-cell lymphoma: A study based on bioinformatics analysis.
    Yan W; Li SX; Gao H; Yang W
    Oncol Lett; 2019 Mar; 17(3):2825-2835. PubMed ID: 30854058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites.
    Wang C; Li W; Liu C; He H; Bai O
    Blood Cells Mol Dis; 2016 Mar; 57():42-9. PubMed ID: 26852654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas.
    Rodig SJ; Kutok JL; Paterson JC; Nitta H; Zhang W; Chapuy B; Tumwine LK; Montes-Moreno S; Agostinelli C; Johnson NA; Ben-Neriah S; Farinha P; Shipp MA; Piris MA; Grogan TM; Pileri SA; Gascoyne RD; Marafioti T
    Haematologica; 2010 Dec; 95(12):2056-62. PubMed ID: 20823132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma.
    Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z
    Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma.
    Xu H; Li Y; Jiang Y; Wang J; Sun H; Wu W; Lv Y; Liu S; Zhai Y; Tian L; Li L; Zhao Z
    Front Genet; 2022; 13():827840. PubMed ID: 35774514
    [No Abstract]   [Full Text] [Related]  

  • 20. Extranodal diffuse large B cell lymphoma of cutaneous follicle centre lymphoma type: a study of 24 patients with non-cutaneous primary limited stage extranodal diffuse large B cell lymphoma in support of a new concept.
    Aigner F; Korol D; Schmitt AM; Kurrer MO
    Histopathology; 2012 Apr; 60(5):774-84. PubMed ID: 22304695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.